Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC)

Clinical and Experimental Immunology

Volumn 104, Issue 2, 1996, Pages 286-292

  Ueki, T ^a   Mizuno, M ^a   Uesu, T ^a   Kiso, T ^a   Nasu, J ^a   Inaba, T ^a   Kihara, Y ^a   Matsuoka, Y ^a   Okada, H ^a   Fujita, T ^b   Tsuji, T ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

C3b; Complement; iC3b C3dg; Ulcerative colitis

Indexed keywords

COMPLEMENT COMPONENT C3B;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOELECTRON MICROSCOPY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 9244231203     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.17721.x     Document Type: Article

References (37)

1. Müller-Eberhard HJ. Complement. Ann Rev Biochem 1975; 44:697-724.
2. Reid KBM, Porter RR. The proteolytic activation systems of complement. Ann Rev Biochem 1981; 50:433-64.
3. Billiard J, Shiner M. Evidence of cytotoxicity in ulcerative colitis from immunofluorescent staining of the rectal mucosa. Lancet 1974; i:1014-7.
4. Gebbers J-O, Otto HF. Immunohistochemical and electronmicroscopic observations on the local immune response in ulcerative colitis. Virchows Arch A Path Anat Histol 1977; 374:271-3.
5. Halstensen TS, Mollnes TE, Garred P et al. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 1990; 98:1264-71.
6. Tamerius JD, Pangburn MK, Müller-Eberhard HJ. Selective inhibition of functional sites of cell-bound C3b by hybridoma-derived antibodies. J Immunol 1982; 128:512-4.
7. Burger R, Deubel U, Hadding U et al.. Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies. J Immunol 1982; 129:2042-50.
8. Iida K, Mitomo K, Fujita T et al. Characterization of three monoclonal antibodies against C3 with selective specificities. Immunology 1987; 62:413-7.
9. Nicholson-Weller A, Burge J, Fearon DT et al. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 1982; 129:184-9.
10. Fujita T, Inoue T, Ogawa K et al. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J Exp Med 1987; 166:1221-8.
11. Okada N, Harada R, Fujita T et al. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol 1989; 1:205-8.
12. Rollins SA, Sims PJ. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 1990; 144:3478-83.
13. Seya T, Turner JR, Atkinson JP. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med 1986; 163:837-55.
14. Uesu T, Mizuno M, Inoue H et al. Enhanced expression of decay accelerating factor (DAF) and CD59/homologous restriction factor 20 (HRF20) on the colonic epithelium of ulcerative colitis. Lab Invest 1995; 72:587-91.
15. Inoue H, Mizuno M, Uesu T et al. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer. Acta Med Okayama 1994; 48:271-7.
16. Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Qua J Med 1961; 30:393-407.
17. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy. J Histochem Cytochem 1974; 22:1077-83.
18. Mollnes TE, Lea T, Harboe M et al. Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol 1985; 22:183-95.
19. Pesando JM, Hoffman P, Abed M. Antibody-induced antigenic modulation is antigen dependent: characterization of 22 proteins on a malignant human B cell line. J Immunol 1986; 137:3689-95.
20. Cook J, Fischer F, Boucheix C et al. Mouse monoclonal antibodies to the human C3b receptor. Molec Immunol 1985; 22:531-9.
21. Keizer GD, Figdor CG, De Vries JE. Sensitive and quantitative determination of monocyte adherence. J Immunol Methods 1986; 95:141-7.
22. Nakane PK, Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem 1974; 22:1084-91.
23. Mizuno M, Brown WR, Vierling JM. Ultrastructural immunocytochemical localization of the asialoglycoprotein receptor in rat hepatocytes. Gastroenterology 1984; 87:763-9.
24. Fearon DT. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci USA 1979; 76:5867-71.
25. Halstensen TS, Das KM, Brandtzaeg P. Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the Mr 40 kDa putative autoantigen in ulcerative colitis. Gut 1993; 34:650-7.
26. Garred P, Mollnes TE, Lea T et al. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c. Scand J Immunol 1988; 27:319-27.
27. Das KM, Dubin R, Nagai T. Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis. Proc Natl Acad Sci USA 1978; 75:4528-32.
28. Das KM, Sakamaki S, Vecchi M et al. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol 1987; 139:77-84.
29. Basset-Seguin N, Dersookian M, Cehrs K et al. C3d,g is present in normal human epidermal basement membrane. J Immunol 1988; 141:1273-80.
30. Leivo I, Engvall E. C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast. J Cell Biol 1986; 103:1091-100.
31. Podolsky DK, Isselbacher KJ. Glycoprotein composition of colonic mucosa: specific alterations in ulcerative colitis. Gastroenterology 1984; 87:991-8.
32. Ikeda K, Sannoh T, Kawasaki N et al. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem 1987; 262:7451-4.
33. Pison U, Kunau WH, Damerau B et al. Induction of leukotriene formation by the anaphylatoxins C3a and C5a (Abst.). Immunobiology 1983; 164:265.
34. 4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984; 86:453-60.
35. Eliakim R, Karmeli F, Razin E et al. Role of platelet-activating factor in ulcerative colitis: enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 1988; 95:1167-72.
36. Todd III RF, Nadler LM, Schlossman SF. Antigens on human monocytes identified by monoclonal antibodies. J Immunol 1981; 126:1435-42.
37. Marks RM, Todd III RF, Ward PA. Rapid induction of neutrophil endothelial adhesion by endothelial complement fixation. Nature 1989; 339:314-7.